These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2704099)

  • 101. Techniques for endovascular treatment of acute ischemic stroke: from intra-arterial fibrinolytics to stent-retrievers.
    Pierot L; Soize S; Benaissa A; Wakhloo AK
    Stroke; 2015 Mar; 46(3):909-14. PubMed ID: 25657185
    [No Abstract]   [Full Text] [Related]  

  • 102. [Current trends in anticoagulant and thrombolytic therapy of thrombosis].
    Gavrilov OK; Rachinskaia NA; Kaveshnikova BF
    Sov Med; 1975 Sep; (9):53-9. PubMed ID: 781864
    [No Abstract]   [Full Text] [Related]  

  • 103. [Current status of thrombolysis. The need for coadjuvant antithrombotic therapy].
    García Frade LJ; García Avello A
    Rev Clin Esp; 1993 Jun; 193(2):88-92. PubMed ID: 8341821
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Current developments in thrombolytic therapy.
    Sherry S
    Thromb Diath Haemorrh Suppl; 1973; 56():201-10. PubMed ID: 4617330
    [No Abstract]   [Full Text] [Related]  

  • 105. [New agents and challenges in the antithrombotic management of arterial diseases].
    Udvardy M; Rák K
    Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617
    [TBL] [Abstract][Full Text] [Related]  

  • 106. [Fibrinolytic therapy].
    Beyer J; Schellong S
    Hamostaseologie; 2005 Nov; 25(4):345-55. PubMed ID: 16395484
    [TBL] [Abstract][Full Text] [Related]  

  • 107. [Therapy and prevention of thromboembolic diseases: anticoagulants and fibrinolytics].
    Pelosio L; Marasco A; Puopolo G
    Clin Ter; 1982 Feb; 100(4):417-25. PubMed ID: 7044661
    [No Abstract]   [Full Text] [Related]  

  • 108. [On fibrinolytic therapy of intravascular thrombosis (review of the literature)].
    Gritsiuk AI
    Ter Arkh; 1967 May; 39(5):12-9. PubMed ID: 4237762
    [No Abstract]   [Full Text] [Related]  

  • 109. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
    Marder VJ; Francis CW
    Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
    [No Abstract]   [Full Text] [Related]  

  • 110. A survey of the clinical experience with dermatan sulfate.
    Gianese F; Lucchelli PE
    Semin Thromb Hemost; 1991; 17 Suppl 2():199-204. PubMed ID: 1948090
    [No Abstract]   [Full Text] [Related]  

  • 111. Fibrinogen- and fibrin-degradation products during fibrinolytic therapy.
    Francis CW; Kornberg A
    Ann N Y Acad Sci; 1992 Dec; 667():310-23. PubMed ID: 1309052
    [No Abstract]   [Full Text] [Related]  

  • 112. [How effective and safe is interventional stroke therapy?].
    Krome S
    Dtsch Med Wochenschr; 2011 Jun; 136(23):1241. PubMed ID: 21630168
    [No Abstract]   [Full Text] [Related]  

  • 113. [An analog-digital system of external pressure for loco-regional treatment of deep venous thrombosis with fibrinolytics].
    Magallón Ortín P; Fernández-Pavón A; Jiménez Cossío AJ
    Angiologia; 1990; 42(2):56-8. PubMed ID: 2187379
    [TBL] [Abstract][Full Text] [Related]  

  • 114. [Fibrinolysis and prospects of fibrinolytic treatment].
    Sarcinelli L; Teofili MT
    Clin Ter; 1967 Apr; 41(1):79-93. PubMed ID: 4881990
    [No Abstract]   [Full Text] [Related]  

  • 115. Treatment of arterial thrombosis with low molecular weight heparins.
    Chesebro JH
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):26-34. PubMed ID: 9399407
    [No Abstract]   [Full Text] [Related]  

  • 116. New antithrombotics.
    Weitz JI; Califf RM; Ginsberg JS; Hirsh J; Théroux P
    Chest; 1995 Oct; 108(4 Suppl):471S-485S. PubMed ID: 7555197
    [No Abstract]   [Full Text] [Related]  

  • 117. [Thrombosis and new antithrombotic agents].
    Drouet L; Mahé I; Le Gal G; Righini M; Quéré I
    Rev Med Interne; 2011 Dec; 32 Suppl 2():S236-40. PubMed ID: 22041519
    [No Abstract]   [Full Text] [Related]  

  • 118. Experimental animal models of arterial thrombosis and the screening of platelet-inhibiting, anti-thrombotic drugs: a review.
    Philp RB
    Methods Find Exp Clin Pharmacol; 1979 Oct; 1(4):197-224. PubMed ID: 399655
    [No Abstract]   [Full Text] [Related]  

  • 119. Copolymer, undergoing trials, could improve fibrinolytics' effectiveness.
    Raymond C
    JAMA; 1989 May; 261(17):2475, 2479-80. PubMed ID: 2704099
    [No Abstract]   [Full Text] [Related]  

  • 120. [Fibrinolytics. 46].
    Wagler M
    Pharm Prax; 1970; 6():141-2. PubMed ID: 4195438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.